Ετικέτες

Τετάρτη 19 Δεκεμβρίου 2018

Preoperative Nerve Block for Rhinoplasty/Septoplasty

Conditions:   Nasal Fracture;   Deviated Nasal Septum
Intervention:   Drug: Nerve block
Sponsor:   University of Southern California
Not yet recruiting

https://ift.tt/2QFkOQt

This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

Conditions:   Carcinoma, Non-Small-Cell Lung;   Head and Neck Neoplasms
Interventions:   Drug: BI 754111;   Drug: [89Zr]Zr-BI 754111;   Drug: BI 754091
Sponsor:   Boehringer Ingelheim
Not yet recruiting

https://ift.tt/2BspW00

Optimizing nitrogen management to balance rice yield and environmental risk in the Yangtze River’s middle reaches

Abstract

Currently, the urgency of balancing rice production and environmental risk from nitrogen (N) fertilization is gaining scientific and public attention. As such, a field experiment was conducted to investigate the rice yield and the fate of applied-15N for Yangliangyou 6 (a two-line hybrid cultivar) and Lvdaoq 7 (an inbred cultivar) using 10 combinations of N rates and splitting ratios in the middle reaches of the Yangtze River. The results showed that N application primarily affected fertilizer N loss to the environment, followed by plant N absorption, but had little effect on grain yield. Generally, there was no significant increase in grain yield and N accumulation in the aboveground plant when N inputs surpassed 130 or 170 kg ha−1. Fertilizer N residue in soil peaked at approximately 48 kg ha−1 at an N rate of 170 kg ha−1 for both varieties; however, a sharp increase of fertilizer N loss occurred with further incrementally increasing N rates. Although a higher ratio of panicle-N fertilizer together with a lower ratio of tillering-N fertilizer at rates of 130, 170, and 210 kg ha−1 had no grain yield benefit, it promoted aboveground N accumulation and plant N accumulation derived from fertilizer, and it reduced the amount of N residue in soil and N loss to the environment. Overall, reducing tillering-N ratios and increasing panicle-N ratios at an N rate between 130 and 170 kg ha−1 using fertilizer rates of 90–0–40 kg ha−1 and 90–40–40 kg ha−1 N at basal-tillering-panicle initiation stages could reduce the adverse environmental risks of chemical N from rice production without sacrificing rice yield.



https://ift.tt/2LssLm9

Successful radiofrequency ablation strategies for benign thyroid nodules

Abstract

Purpose

This study aimed to evaluate the effectiveness of ultrasound (US)-guided radiofrequency ablation (RFA) treatment of benign thyroid nodules in consecutive large number series. To find out whether there is any difference according to the nature of the nodules, nodules were subdivided into two groups of predominantly solid vs. predominantly cystic lesions.

Methods

We retrospectively analyzed clinical data of thyroid nodules receiving percutaneous RFA treatment in our institution. We subdivided data into two groups according to the nodule's sonographic characteristics. We defined therapeutic success as a volume reduction rate >50% at 6 months post-RFA. The second ablation was performed in case where <50% VRR was achieved at 6 months. The primary endpoint was to identify factors prognosticating response to RFA treatment.

Results

A total of 1000 patients with 1619 thyroid nodules received US-guided RFA treatment. A volume reduction of >50% (therapeutic success) after the first ablation was 78.9% vs. 78.2% (p = 0.439) and 91.4% vs. 93.4% (p = 0.148) after the final ablation for predominantly cystic vs. predominantly solid lesions, respectively, with comparable post-interventional morbidity. RFA sessions were more frequent in the solid group than in the cystic group. Small volume of thyroid nodule (<4 mL) was the only factor significantly associated with therapeutic success in the multivariate analysis (OR 1.848; 95% CI 1.537–2.789, p = 0.030).

Conclusion

RFA was effective in reducing the volume of benign thyroid nodules volume with non-inferior result in PS group comparing to PC group and can be considered a principal treatment method for treating benign thyroid nodules, including cystic nodules.



https://ift.tt/2EE6Gkm

Excess mortality after craniopharyngioma treatment: are we making progress?

Abstract

Purpose

Craniopharyngioma is associated with an increased risk of mortality even after surgical, radiotherapeutic and hormone supplementations. Previous studies using different designs showed a possible trend of decreasing mortality in recent years. This review summarises studies reporting standardised mortality ratio (SMR) after craniopharyngioma treatment, as well as the bias and confounding in these studies to plan further researches.

Methods

PubMed and Embase was searched for manuscripts published before October 2018 using medical subject heading terms ("craniopharyngioma" or "hypopituitarism" and "mortality").

Results

Eight studies reported SMR after craniopharyngioma treatment, with a total of 2802 patients. The subgroup meta-analysis using random effects model was conducted to pool the SMR, which was 6.2 (95% CI 4.1–9.4) before 2010 and 2.9 (95% CI 2.2–3.8) after 2010 (subgroup test p < 0.01), respectively. Misclassification (one study) and selection bias (six studies) either inflated or deflated the result. The trend of increasing survival rate over the time was observed in studies without reporting SMR. Female patients, childhood-onset disease, hydrocephalus, tumour recurrence, body mass index and panhypopituitarism were identified as the important risk factors for excess mortality.

Conclusions

Though bias and confounding existed across studies, the decreasing SMR and increasing survival rate over the time was in favour of a real signal. It is necessary to launch studies to further investigate the morality and risk factors after multidisciplinary treatment of craniopharyngioma in a hospital-based manner, using the modern statistical method to adjust for bias and confounding.



https://ift.tt/2EwryZG

3D-Printed Conformal Array Patch Antenna Using a Five-Axes Motion Printing System and Flash Light Sintering

3D Printing and Additive Manufacturing, Ahead of Print.


https://ift.tt/2Bt3tjx

Correction to: Cadmium exposure alters steroid receptors and proinflammatory cytokine levels in endothelial cells in vitro: a potential mechanism of endocrine disruptor atherogenic effect

Unfortunately, the figure captions 4 and 6 were incorrectly published in the original publication. The complete correct captions are given below.



https://ift.tt/2R5G5Ct

Successful radiofrequency ablation strategies for benign thyroid nodules

Abstract

Purpose

This study aimed to evaluate the effectiveness of ultrasound (US)-guided radiofrequency ablation (RFA) treatment of benign thyroid nodules in consecutive large number series. To find out whether there is any difference according to the nature of the nodules, nodules were subdivided into two groups of predominantly solid vs. predominantly cystic lesions.

Methods

We retrospectively analyzed clinical data of thyroid nodules receiving percutaneous RFA treatment in our institution. We subdivided data into two groups according to the nodule's sonographic characteristics. We defined therapeutic success as a volume reduction rate >50% at 6 months post-RFA. The second ablation was performed in case where <50% VRR was achieved at 6 months. The primary endpoint was to identify factors prognosticating response to RFA treatment.

Results

A total of 1000 patients with 1619 thyroid nodules received US-guided RFA treatment. A volume reduction of >50% (therapeutic success) after the first ablation was 78.9% vs. 78.2% (p = 0.439) and 91.4% vs. 93.4% (p = 0.148) after the final ablation for predominantly cystic vs. predominantly solid lesions, respectively, with comparable post-interventional morbidity. RFA sessions were more frequent in the solid group than in the cystic group. Small volume of thyroid nodule (<4 mL) was the only factor significantly associated with therapeutic success in the multivariate analysis (OR 1.848; 95% CI 1.537–2.789, p = 0.030).

Conclusion

RFA was effective in reducing the volume of benign thyroid nodules volume with non-inferior result in PS group comparing to PC group and can be considered a principal treatment method for treating benign thyroid nodules, including cystic nodules.



https://ift.tt/2EE6Gkm

Excess mortality after craniopharyngioma treatment: are we making progress?

Abstract

Purpose

Craniopharyngioma is associated with an increased risk of mortality even after surgical, radiotherapeutic and hormone supplementations. Previous studies using different designs showed a possible trend of decreasing mortality in recent years. This review summarises studies reporting standardised mortality ratio (SMR) after craniopharyngioma treatment, as well as the bias and confounding in these studies to plan further researches.

Methods

PubMed and Embase was searched for manuscripts published before October 2018 using medical subject heading terms ("craniopharyngioma" or "hypopituitarism" and "mortality").

Results

Eight studies reported SMR after craniopharyngioma treatment, with a total of 2802 patients. The subgroup meta-analysis using random effects model was conducted to pool the SMR, which was 6.2 (95% CI 4.1–9.4) before 2010 and 2.9 (95% CI 2.2–3.8) after 2010 (subgroup test p < 0.01), respectively. Misclassification (one study) and selection bias (six studies) either inflated or deflated the result. The trend of increasing survival rate over the time was observed in studies without reporting SMR. Female patients, childhood-onset disease, hydrocephalus, tumour recurrence, body mass index and panhypopituitarism were identified as the important risk factors for excess mortality.

Conclusions

Though bias and confounding existed across studies, the decreasing SMR and increasing survival rate over the time was in favour of a real signal. It is necessary to launch studies to further investigate the morality and risk factors after multidisciplinary treatment of craniopharyngioma in a hospital-based manner, using the modern statistical method to adjust for bias and confounding.



https://ift.tt/2EwryZG

Ex Vivo Confocal Microscopy Of Basal Cell Carcinoma On A 3-Color Scale

Publication date: Available online 19 December 2018

Source: Journal of the American Academy of Dermatology

Author(s): Mercedes Sendín-Martín, Antoni Bennàssar, Konstantin L. Levitsky, Javier J. Domínguez-Cruz



https://ift.tt/2UQljFQ

Delayed cutaneous knot for closing defects located in the retroauricular fold

Publication date: Available online 19 December 2018

Source: Journal of the American Academy of Dermatology

Author(s): Javier Sabater Abad, Fernando Millán Parrilla, María Matellanes Palacios, Esther Quecedo Estébanez, Enrique Gimeno Carpio



https://ift.tt/2PNPJol

“Retraction of the cheek to enhance visualization of the nasolabial fold region”

Publication date: Available online 19 December 2018

Source: Journal of the American Academy of Dermatology

Author(s): Isadore S. Tarantino, Jacob Whitsitt, Rachel T. Pflederer, Daniel J. Aires



https://ift.tt/2POg9qn

Tumor mutational burden and response to PD-1 inhibitors in a case series of patients with metastatic desmoplastic melanoma

Publication date: Available online 18 December 2018

Source: Journal of the American Academy of Dermatology

Author(s): Lise Boussemart, Adrienne Johnson, Alexa B. Schrock, Sumanta K. Pal, Garrett M. Frampton, David Fabrizio, Zachary Chalmers, Michal Lotem, Geoffrey Gibney, Jeffery Russell, Bartosz Chmielowski, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali

Abstract

Desmoplastic melanoma (DM) represents an infrequently occurring and distinct histologic pattern of melanomas, often lacking mutations in genes typically altered in conventional melanomas including BRAF, NRAS, and KIT.

We aimed at better characterizing the genetic profile of this subgroup of melanomas to match patients with available therapies.

Pathology reports were reviewed for 1,240 consecutive melanoma cases sequenced by comprehensive genomic profiling (CGP) using a hybrid-capture based next generation sequencing during the course of clinical care. The mutational profile of the 12 DM identified was compared with the remaining 1,228 melanomas examined.

We report a median tumor mutational burden (TMB) of 77 mutations per megabase (mut/Mb) in DM, which was significantly greater than a median of 35 mut/Mb in non-DM. A UV DNA damage signature was detected in 10/12 (83%) DM. For a subset of patients with available clinical course, we report that 100% (5/5) had clinical benefit from treatment with PD-1 inhibitors as monotherapy.

TMB and UV signature show significant promise as an approach to identify patients who are likely to benefit from PD-1 targeted immunotherapy.



https://ift.tt/2UVHdYl

TNF-α Inhibitor-Induced psoriasis: A decade of experience at the Cleveland Clinic

Publication date: Available online 18 December 2018

Source: Journal of the American Academy of Dermatology

Author(s): Sean E. Mazloom, Di Yan, Jeffery Z. Hu, Jason Ya, M. Elaine Husni, Christine B. Warren, Anthony P. Fernandez

Abstract
Background

TNF-α inhibitor-induced psoriasis (TNFi-psoriasis) remains poorly understood despite being described 15 years ago. As TNF-α inhibitors (TNFis) often provide life-changing patient benefits, understanding effective treatments for TNFi-psoriasis is important.

Objective

We characterized a cohort of TNFi-psoriasis patients specifically diagnosed and (co)managed by dermatologists at a single tertiary care institution over a ten-year period.

Methods

Retrospective review of patients diagnosed with TNFi-psoriasis between 2003-2013.

Results

102 patients with TNFi-psoriasis were identified. Mean age of onset was 40 years, and there was a female predominance(73.5%). Crohn's disease(48%) and rheumatoid arthritis(24.5%) were the most common primary conditions. Infliximab(52%) was the most common inciting agent. The most common TNFi-psoriasis subtypes were plaque-type(49.5%), scalp(47.5%), and palmoplantar pustulosis(41%). Topical medications alone improved/resolved TNFi-psoriasis in 63.5% patients, and cyclosporine and methotrexate (>10mg weekly) were often effective if topicals failed. Discontinuation of the inciting TNFi with/without other interventions improved/resolved TNFi-psoriasis in 67% of refractory cases, while switching TNFis resulted in persistence/recurrence in 64%.

Limitations

Retrospective nature of study and some patients may have developed typical psoriasis unresponsive to TNFis,

Conclusion

This represents the largest single-institution cohort of TNFi-psoriasis patients diagnosed and (co)managed by dermatologists to date. Based on our findings we propose a treatment algorithm for TNFi-psoriasis.



https://ift.tt/2POTQkm

Wide area digital dermoscopy

Publication date: Available online 18 December 2018

Source: Journal of the American Academy of Dermatology

Author(s): Gerson Dellatorre, Guilherme Augusto Gadens



https://ift.tt/2USS0Tj

Editorial Board and Contents

Publication date: January 2019

Source: Trends in Endocrinology & Metabolism, Volume 30, Issue 1

Author(s):



https://ift.tt/2PORBNY

Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis

Publication date: Available online 18 December 2018

Source: Journal of Autoimmunity

Author(s): José A. Villegas, Alexandra C. Bayer, Katia Ider, Jacky Bismuth, Frédérique Truffault, Régine Roussin, Nicola Santelmo, Rozen Le Panse, Sonia Berrih-Aknin, Nadine Dragin

Abstract

IL-23/Th17 pathway has been identified to sustain inflammatory condition in several autoimmune diseases and therefore being targeted in various therapeutic and effective approaches. Patients affected with autoimmune myasthenia gravis exhibit a disease effector tissue, the thymus, that harbors ectopic germinal centers that sustain production of auto-antibodies, targeting proteins located in the neuromuscular junction, cause of the organ-specific chronic autoimmune disease.

The present study aims to investigate the IL-23/Th17 cell pathway in the thymic inflammatory and pathogenic events.

We found that thymuses of MG patients displayed overexpression of Interleukin-17, signature cytokine of activated Th17 cells. This activation was sustained by a higher secretion of Interleukin-23 by TEC, in addition to the increased expression of cytokines involved in Th17 cell development. The overexpression of Interleukin-23 was due to a dysregulation of interferon type I pathway. Besides, Interleukin-17 secreted, and Th17 cells were localized around thymic ectopic germinal centers. These cells expressed podoplanin, a protein involved in B-cell maturation and antibody secretion. Finally, production of Interleukin-23 was also promoted by Interleukin-17 secreted itself by Th17 cells, highlighting a chronic loop of inflammation sustained by thymic cell interaction.

Activation of the IL-23/Th17 pathway in the thymus of autoimmune myasthenia gravis patients creates an unstoppable loop of inflammation that may participate in ectopic germinal center maintenance. To alleviate the physio-pathological events in myasthenia gravis patients, this pathway may be considered as a new therapeutic target.



https://ift.tt/2R8HkRh

Sustainable utilization of a recovered struvite/diatomite compound for lead immobilization in contaminated soil: potential, mechanism, efficiency, and risk assessment

Abstract

A waste–struvite/diatomite compound (MAP@Dia) recovered from nutrient-rich wastewater treated by MgO-modified diatomite (MgO@Dia) was provided to immobilize lead in aqueous solution and contaminated soil. The mechanism and effectiveness of lead immobilization was investigated, and the pHstat leaching test and fixed-bed column experiments were carried out to assess the risk of MAP@Dia reuse for lead immobilization. The results showed that MAP@Dia were effective in immobilizing lead in aqueous solution with adsorption capacity of 832.47–946.50 mg/g. The main mechanism of Pb immobilization by MAP@Dia could be contributed by surface complexation and dissolution of struvite followed by precipitation of hydroxypyromorphite Pb10(PO4)6(OH)2. Lead(II) concentration reduced from 269.61 to 78.26 mg/kg, and residual lead(II) increased to 53.14% in contaminated soil when the MAP@Dia application rate was 5%. The increased neutralization capacity (ANC) and lower lead extraction yields in pHstat leaching test in amended soil suggested 5 times of buffering capacity against potential acidic stresses and delayed triggering of "chemical time bombs." The results of column studies demonstrated that amendment with MAP@Dia could reduce the risk of lead and phosphorus (P) leaching. This study revealed that MAP@Dia could provide an effective solution for both P recycling and lead immobilization in contaminated soil.



https://ift.tt/2QHu2vM

Inference and control of the nosocomial transmission of methicillin-resistant Staphylococcus aureus.

Related Articles

Inference and control of the nosocomial transmission of methicillin-resistant Staphylococcus aureus.

Elife. 2018 Dec 18;7:

Authors: Pei S, Morone F, Liljeros F, Makse H, Shaman JL

Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a continued threat to human health in both community and healthcare settings. In hospitals, control efforts would benefit from accurate estimation of asymptomatic colonization and infection importation rates from the community. However, developing such estimates remains challenging due to limited observation of colonization and complicated transmission dynamics within hospitals and the community. Here, we develop an inference framework that can estimate these key quantities by combining statistical filtering techniques, an agent-based model, and real-world patient-to-patient contact networks, and use this framework to infer nosocomial transmission and infection importation over an outbreak spanning 6 years in 66 Swedish hospitals. In particular, we identify a small number of patients with disproportionately high risk of colonization. In retrospective control experiments, interventions targeted to these individuals yield a substantial improvement over heuristic strategies informed by number of contacts, length of stay and contact tracing.

PMID: 30560786 [PubMed - in process]



https://ift.tt/2BueReJ

Localization of Deep Brain Stimulation Electrode by Image Registration Is Software Dependent: A Comparative Study between Four Widely Used Software Programs

Background: The control of the anatomic position of the active contacts is essential to understand the effects and adapt the settings of the neurostimulation. The localization is commonly assessed by a registration between the preoperative MRI and the postoperative CT scan. However, its accuracy depends on the quality of the registration algorithm and many software programs are available. Objective: To compare the localization of implanted deep brain stimulation (DBS) leads in the subthalamic nucleus (STN) between four registration devices. Methods: The preoperative stereotactic MRI was co-registered and fused with the 3-month postoperative CT scan in 27 patients implanted in the STN for Parkinson's disease (53 leads). Localizations of the active contacts were calculated in the stereotactic frame space and compared between software programs. Results: The coordinates of the active contacts were different between software programs in the 3 axes (p #x3c; 0.001) with a mean vectorial error between the deepest contact locations of 1.17 mm (95% CI 1.09–1.25). Conclusion: We found a small but significant difference in the coordinates calculated on four different devices. These results have to be considered when performing studies comparing active contact locations or when following patients with an implanted DBS lead.
Stereotact Funct Neurosurg

https://ift.tt/2ECJPFM

Αναζήτηση αυτού του ιστολογίου